Volume 3 - 2024

Brief Research Report

Published on 04 Apr 2024

Constructing a novel clinical indicator model to predicate the occurrence of thalassemia in pregnancy through machine learning algorithm

Yaoshui Long
Wenxue Bai

Frontiers in Hematology

doi 10.3389/frhem.2024.1341225

314 views

Clinical Trial

Published on 28 Mar 2024

Phase II Single-Arm Study of a Combination of Obinutuzumab and Venetoclax in Early Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) -Final Results of the AGMT NHL15B Study

Ulrich Jaeger
Alexander Egle
Ingrid Simonitsch-Klupp
Sonja Heibl
Peter Neumeister
Ella Willenbacher
Florian Erlsbacher
Julian Larcher-Senn
Philipp B Staber
Edit Porpaczy

Frontiers in Hematology

doi 10.3389/frhem.2024.1331008

346 views

Review

Published on 28 Mar 2024

Blood Pharming: Exploring the Progress and Hurdles in Producing in-vitro Red Blood Cells for Therapeutic Applications

Hammad Hassan
Sheerien Rajput

Frontiers in Hematology

doi 10.3389/frhem.2024.1373408

846 views

Review

Published on 26 Mar 2024

Asymmetric Cell Division of Hematopoietic Stem Cells: Recent Advances, Emerging Concepts, and Future Perspectives

Jessica Nunes
Dirk Loeffler

Frontiers in Hematology

doi 10.3389/frhem.2024.1373554

711 views

Case Report

Published on 21 Mar 2024

Donor Lymphocyte Infusion and Blinatumomab as treatment for Acute Lymphoblastic Leukemia relapse after allogeneic hematopoietic stem cell transplantation

Flavia Antonucci
Serena Marotta
Maria Celentano
Mariangela Pedata
Cira Riccardi
Angela Carobene
Stefania leone
Ilaria Migliaccio
Simona Maria Muggianu
Assunta Viola

Frontiers in Hematology

doi 10.3389/frhem.2024.1345884

309 views

Opinion

Published on 18 Mar 2024

The impact of NETosis on hematological malignancies as a promising therapeutic target

Duygu Aydemir

Frontiers in Hematology

doi 10.3389/frhem.2024.1377806

415 views

Review

Published on 08 Mar 2024

Management of Secondary Immunodeficiency in Hematological Malignancies: A Delphi Consensus from the Middle East

Maria Dimou
Mohamed Abuzakouk
Mona Al Ahmad
Khalil Al Farsi
Ahmad Alhuraiji
Fayhan Al Roqi
Ahmed Alsaeed
Mohsen Alzahrani
Ali Bazarbachi
Honar Cherif

Frontiers in Hematology

doi 10.3389/frhem.2024.1347708

887 views

Case Report

Published on 06 Mar 2024

Case Report: Childhood Erythrocytosis due to Hypermanganesemia Caused by Homozygous SLC30A10 Mutation

Tiziana Coppola
Hannah Hughes
Paul Finch
Joshua Hess
Steve W Wu
Carlos Prada
Alexander Gerhard Miethke
Wenying Zhang
Theodosia A. Kalfa

Frontiers in Hematology

doi 10.3389/frhem.2024.1331485

412 views

Case Report

Published on 06 Mar 2024

A patient with ALK-positive large B-cell lymphoma benefit from myeloma-like treatment combined with ALK inhibitor lorlatinib

Dan Liu
Lijie Xing
Hui Wang
Ping Li
Haichen Wei
Zengjun Li

Frontiers in Hematology

doi 10.3389/frhem.2024.1334577

413 views

Review

Published on 01 Mar 2024

Exploring the intricate cross-talk between clonal expansion and the bone marrow niche

Steven Ngo
Despoina Papazoglou
Hector Huerga Encabo
Dominique Bonnet

Frontiers in Hematology

doi 10.3389/frhem.2024.1334807

756 views

Review

Published on 19 Feb 2024

Hypersialylation and multiple myeloma

Michael O’Dwyer
Siobhan Glavey
Roisin McAvera
Alessandro Natoni
Aideen E. Ryan

Frontiers in Hematology

doi 10.3389/frhem.2024.1360149

1,002 views

Review

Published on 15 Feb 2024

Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer

Guillermo Garcia-Manero
Uwe Platzbecker
Kian-Huat Lim
Grzegorz Nowakowski
Omar Abdel-Wahab
Hagop Kantarjian
Amit Verma
Daniel T. Starczynowski

Frontiers in Hematology

doi 10.3389/frhem.2024.1339870

1,439 views
2 citations

Original Research

Published on 05 Feb 2024

Predicting factors of survival rates among alpha- and beta-thalassemia patients: a retrospective 10-year data analysis

Kunapa Iam-arunthai
Tawatchai Suwanban
Pravinwan Thungthong
Supat Chamnanchanunt
Suthat Fucharoen

Frontiers in Hematology

doi 10.3389/frhem.2024.1339026

1,407 views

Review

Published on 02 Feb 2024

How artificial intelligence revolutionizes the world of multiple myeloma

Martha Romero
Adrián Mosquera Orgueira
Mateo Mejía Saldarriaga

Frontiers in Hematology

doi 10.3389/frhem.2024.1331109

1,360 views
1 citation

Review

Published on 25 Jan 2024

De novo drug design through artificial intelligence: an introduction

Davide Crucitti
Carlos Pérez Míguez
José Ángel Díaz Arias
Diego Beltrán Fernandez Prada
Adrián Mosquera Orgueira

Frontiers in Hematology

doi 10.3389/frhem.2024.1305741

2,741 views

Volume 2 - 2023

Brief Research Report

Published on 25 Jan 2024

Concanavalin A staining: a potential biomarker to predict cytarabine sensitivity in acute myeloid leukemia

Tao Zhang
Glenn Marsman
Diego A. Pereira-Martins
Manfred Wuhrer
Gerwin A. Huls
Valerie R. Wiersma

Frontiers in Hematology

doi 10.3389/frhem.2023.1302328

646 views

Navigation group

Volumes

Volume 3 - 2024

Constructing a novel clinical indicator model to predicate the occurrence of thalassemia in pregnancy through machine learning algorithm

Phase II Single-Arm Study of a Combination of Obinutuzumab and Venetoclax in Early Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) -Final Results of the AGMT NHL15B Study

Blood Pharming: Exploring the Progress and Hurdles in Producing in-vitro Red Blood Cells for Therapeutic Applications

Asymmetric Cell Division of Hematopoietic Stem Cells: Recent Advances, Emerging Concepts, and Future Perspectives

Donor Lymphocyte Infusion and Blinatumomab as treatment for Acute Lymphoblastic Leukemia relapse after allogeneic hematopoietic stem cell transplantation

The impact of NETosis on hematological malignancies as a promising therapeutic target

Management of Secondary Immunodeficiency in Hematological Malignancies: A Delphi Consensus from the Middle East

Case Report: Childhood Erythrocytosis due to Hypermanganesemia Caused by Homozygous SLC30A10 Mutation

A patient with ALK-positive large B-cell lymphoma benefit from myeloma-like treatment combined with ALK inhibitor lorlatinib

Exploring the intricate cross-talk between clonal expansion and the bone marrow niche

Hypersialylation and multiple myeloma

Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer

Predicting factors of survival rates among alpha- and beta-thalassemia patients: a retrospective 10-year data analysis

How artificial intelligence revolutionizes the world of multiple myeloma

De novo drug design through artificial intelligence: an introduction

Volume 2 - 2023

Concanavalin A staining: a potential biomarker to predict cytarabine sensitivity in acute myeloid leukemia